The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Jelly Roll expressed his gratitude after the Tennessee Board of Parole unanimously voted to recommend the “Lonely Road” ...

Indiana University School of Medicine scientists have developed a powerful new imaging technique to study bone marrow in ...

In this episode presented by DIA, BioSpace's head of insights Lori Ellis discusses the underrepresentation of women in ...

A controversial provision within President Joe Biden's Inflation Reduction Act (IRA) is drawing growing backlash from ...

Saini inaugurated 923 development projects valued at ₹233 crore and laid the foundation stones for 413 additional projects, ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in ...

A conference call will be held today, April 25, 2025, at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) to review the ...

Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...